← Browse by Condition
Medical Condition
antineoplastic agents
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2, Phase 1
NCT06755684 Phase 2
Recruiting
Neoadjuvant Befotertinib Combined Bevacizumab or Platinum-based Double Chemotherapy for Resectable Locally-advanced EGFR Mutation-positive Non-Small Cell Lung Cancer
Enrollment
60 pts
Location
China
Sponsor
Peng Zhang
NCT04572451 Phase 1
Recruiting
Safety of SBRT With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors and Melanoma
Enrollment
50 pts
Location
United States
Sponsor
Yana Najjar